139 related articles for article (PubMed ID: 19447065)
1. Excessive daytime sleepiness in cervical dystonia.
Trotti LM; Esper CD; Feustel PJ; Bliwise DL; Factor SA
Parkinsonism Relat Disord; 2009 Dec; 15(10):784-6. PubMed ID: 19447065
[TBL] [Abstract][Full Text] [Related]
2. Sleepiness in Parkinson's disease: a controlled study.
Brodsky MA; Godbold J; Roth T; Olanow CW
Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical rating scales in treatment of cervical dystonia with botulinum toxin.
Tarsy D
Mov Disord; 1997 Jan; 12(1):100-2. PubMed ID: 8990061
[TBL] [Abstract][Full Text] [Related]
4. Daytime sleepiness in stable hemodialysis patients.
Parker KP; Bliwise DL; Bailey JL; Rye DB
Am J Kidney Dis; 2003 Feb; 41(2):394-402. PubMed ID: 12552502
[TBL] [Abstract][Full Text] [Related]
5. Daytime sleepiness is not increased in mild to moderate multiple sclerosis: a pupillographic study.
Frauscher B; Egg R; Brandauer E; Ulmer H; Berger T; Poewe W; Högl B
Sleep Med; 2005 Nov; 6(6):543-7. PubMed ID: 16084765
[TBL] [Abstract][Full Text] [Related]
6. The Epworth sleepiness scale: relationship to sleep and mental disorders in a sleep clinic.
DeZee KJ; Jackson JL; Hatzigeorgiou C; Kristo D
Sleep Med; 2006 Jun; 7(4):327-32. PubMed ID: 16564218
[TBL] [Abstract][Full Text] [Related]
7. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
[TBL] [Abstract][Full Text] [Related]
8. Patients cured from craniopharyngioma or nonfunctioning pituitary macroadenoma (NFMA) suffer similarly from increased daytime somnolence despite normal sleep patterns compared to healthy controls.
van der Klaauw AA; Biermasz NR; Pereira AM; van Kralingen KW; Dekkers OM; Rabe KF; Smit JW; Romijn JA
Clin Endocrinol (Oxf); 2008 Nov; 69(5):769-74. PubMed ID: 18435832
[TBL] [Abstract][Full Text] [Related]
9. Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study.
Vignatelli L; Bisulli F; Naldi I; Ferioli S; Pittau F; Provini F; Plazzi G; Vetrugno R; Montagna P; Tinuper P
Epilepsia; 2006; 47 Suppl 5():73-7. PubMed ID: 17239111
[TBL] [Abstract][Full Text] [Related]
10. The impact of obstructive sleep apnea and daytime sleepiness on work limitation.
Mulgrew AT; Ryan CF; Fleetham JA; Cheema R; Fox N; Koehoorn M; Fitzgerald JM; Marra C; Ayas NT
Sleep Med; 2007 Dec; 9(1):42-53. PubMed ID: 17825611
[TBL] [Abstract][Full Text] [Related]
11. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease.
Suzuki K; Miyamoto T; Miyamoto M; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
J Neurol Sci; 2008 Aug; 271(1-2):47-52. PubMed ID: 18436241
[TBL] [Abstract][Full Text] [Related]
12. Comparing MSLT and ESS in the measurement of excessive daytime sleepiness in obstructive sleep apnoea syndrome.
Fong SY; Ho CK; Wing YK
J Psychosom Res; 2005 Jan; 58(1):55-60. PubMed ID: 15771871
[TBL] [Abstract][Full Text] [Related]
13. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression.
Iaboni A; Ibanez D; Gladman DD; Urowitz MB; Moldofsky H
J Rheumatol; 2006 Dec; 33(12):2453-7. PubMed ID: 17143980
[TBL] [Abstract][Full Text] [Related]
14. Response shift in perception of sleepiness in obstructive sleep apnea-hypopnea syndrome before and after treatment with nasal CPAP.
Chin K; Fukuhara S; Takahashi K; Sumi K; Nakamura T; Matsumoto H; Niimi A; Hattori N; Mishima M; Nakamura T
Sleep; 2004 May; 27(3):490-3. PubMed ID: 15164904
[TBL] [Abstract][Full Text] [Related]
15. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
[TBL] [Abstract][Full Text] [Related]
16. Rating scales for inattention and sleepiness are correlated in adults with symptoms of sleep disordered breathing syndrome, but not in adults with symptoms of attention-deficit/hyperactivity disorder.
Sangal RB; Sangal JM
Sleep Med; 2004 Mar; 5(2):133-5. PubMed ID: 15033132
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
18. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
Razmy A; Lang AE; Shapiro CM
Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626
[TBL] [Abstract][Full Text] [Related]
19. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing.
Melendres MC; Lutz JM; Rubin ED; Marcus CL
Pediatrics; 2004 Sep; 114(3):768-75. PubMed ID: 15342852
[TBL] [Abstract][Full Text] [Related]
20. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
